A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
| Share Statistics | BCLI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $11.6 | $249.2 | 7% |
|
| Shares Out (Mil) | 11.0 | 53.9 | 22% |
|
| Institutional Ownership | na | 93.0% | na |
|
| Float (Mil) | na | 41.4 | na |
|
| Beta | 0.26 | 0.95 | 16% |
|
| Avg Daily Volume (000s) | 10 | 631 | 17% |
|
| Price Change (52-week) |
45.8% | 49.2% | 82% |
|
| Growth | BCLI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 12.5% | na |
|
| Net Income (5yr) | 20.2% | (10.1%) | 74% |
|
| EPS (5yr) | 41.3% | 15.8% | 89 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | (14.9%) | (15.7%) | 53% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | 1 | 1 | |
| Current EPS | na | ($0.910) | ($1.020) | |
| Month Ago EPS | na | ($0.910) | ($1.020) | |
| # Rev Up | na | 0 | 0 | |
| # Rev Down | na | 1 | 1 | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | (18.2%) | (60.4%) | |
| Financials | BCLI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($11) | ($44) | 29% |
|
| EPS (TTM) | ($0.953) | ($1.600) | 22% |
|
| Operating Cash Flow (TTM) (Mil) | ($4) | ($33) | 26% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | $11 | $175 | 8% |
|
| Valuation | BCLI | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.42 | na |
|
| P/E | na | 19.2 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | BCLI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 67.3% | na |
|
| Net Margin | na | (74.8%) | na |
|
| ROA | (627.4%) | (47.7%) | 0% |
|
| ROE | 119.2% | (54.6%) | 97% |
|
| Liabilities to Assets | na | 29.3% | na |
|
| F-Score | na | 3 | % |
|
Brainstorm Cell Therapeutics Inc. did not pass any screens on 10/5/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
